Literature DB >> 14575760

A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season.

Naoki Kawai1, Hideyuki Ikematsu, Norio Iwaki, Ietaka Satoh, Takashi Kawashima, Taizo Tsuchimoto, Seizaburo Kashiwagi.   

Abstract

The effectiveness of the influenza vaccine used in the 2001-2002 influenza season in Japan was investigated in a large-scale, geographically widely distributed, Internet-based study. Data were collected from 8841 of 9902 subjects registered by 38 clinics prior to the start of influenza season. Subjects were categorized into three groups by vaccination regimen: unvaccinated, vaccinated once, and vaccinated twice. Efficacy was also analyzed for three age groups: 0-15, 16-64, and 65-104 years. Influenza-like illness (ILI) was diagnosed according to Ministry of Health (MWH, Labor and Welfare in Japan) criteria. Laboratory-confirmed influenza cases were analyzed separately. The respective vaccine efficacy in the 0-15 years group for the one- and two-dose regimens was 67.6 and 84.5% for ILI and 54.0 and 79.8% for laboratory-confirmed influenza. Influenza vaccination was also shown to be effective in subjects 16-64 years. Vaccine effectiveness was not able to be determined for the over 65 years group, probably due to an insufficient number of infected patients. These results suggest that influenza vaccination is effective for children and adults and that a two-dose regimen is superior to a single dose in children 0-15 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575760     DOI: 10.1016/s0264-410x(03)00508-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Influenza pandemic preparedness in France: modelling the impact of interventions.

Authors:  Aoife Doyle; Isabelle Bonmarin; Daniel Lévy-Bruhl; Yann Le Strat; Jean-Claude Desenclos
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

2.  Quantifying influenza vaccine efficacy and antigenic distance.

Authors:  Vishal Gupta; David J Earl; Michael W Deem
Journal:  Vaccine       Date:  2006-01-19       Impact factor: 3.641

3.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

4.  Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Authors:  Lidia Brydak; Julie Roiz; Pascaline Faivre; Camille Reygrobellet
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

Review 5.  Vaccines for preventing influenza in healthy children.

Authors:  Tom Jefferson; Alessandro Rivetti; Carlo Di Pietrantonj; Vittorio Demicheli; Eliana Ferroni
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Authors:  Camille Pelat; Alessandra Falchi; Fabrice Carrat; Anne Mosnier; Isabelle Bonmarin; Clément Turbelin; Sophie Vaux; Sylvie van der Werf; Jean Marie Cohen; Bruno Lina; Thierry Blanchon; Thomas Hanslik
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

7.  Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.

Authors:  Masayoshi Shinjoh; Norio Sugaya; Yoshio Yamaguchi; Yuka Tomidokoro; Shinichiro Sekiguchi; Keiko Mitamura; Motoko Fujino; Hiroyuki Shiro; Osamu Komiyama; Nobuhiko Taguchi; Yuji Nakata; Naoko Yoshida; Atsushi Narabayashi; Michiko Myokai; Masanori Sato; Munehiro Furuichi; Hiroaki Baba; Hisayo Fujita; Akihiro Sato; Ichiro Ookawara; Kenichiro Tsunematsu; Makoto Yoshida; Mio Kono; Fumie Tanaka; Chiharu Kawakami; Takahisa Kimiya; Takao Takahashi; Satoshi Iwata
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 8.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 9.  Vaccines for preventing influenza in healthy children.

Authors:  Tom Jefferson; Alessandro Rivetti; Carlo Di Pietrantonj; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 10.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.